Vignettes
Review
Article: Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro
A, Daley C, et al. An Official ATS/IDSA Statement: Diagnosis, Treatment,
and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir
Crit Car Med 2007;175:367-416.
Review Article:
Adhikari P, Mietzner T. Cell Mediated Immunity. 2008. Milanes-Virelles MT,
Garcia-Garcia I, et al.
Adjuvant interferon gamma in patients with pulmonary
atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled
study. BMC Infect Dis. 2008 Feb 11;8(1):17 [Epub ahead of
print].
Guideline: An Official ATS/IDSA
Statement: Diagnosis, Treatment, and Prevention of Nontuberculosis
Mycobacterial Diseases. Am J Respir Crit Care Med 2007:175;367-416.
Murray, MP et al.
Outcomes of a Standardized Triple-drug Regimen for the
Treatment of Nontuberculous Mycobacterial Pulmonary Infection.Clin
Infect Dis. 2008 Jul 15;47:222-4.
Deresinski S
et al.
Natural History of Lymphadenitis due to Nontuberculous
Mycobacteria (NTM).
Clin Infect Dis. 2009 Jan 15;48(2):iv.
Hasegawa N, et al.
Therapeutic Effects of Various Initial Combination
Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex
Pulmonary Disease. Chest. 2009 Jun 19. [Epub ahead of
print]
Winthrop KL, Chang E, et al.
Nontuberculous Mycobacteria Infections and Anti-Tumor
Necrosis Factor-Alpha Therapy. Emerg Infect Dis. 2009
Oct;15:1556-61.
Nishiuchi Y, Maekura R, et al.
The Recovery of Mycobacterium avium-intracellulare
Complex (MAC) from the Residential Bathrooms of Patients with Pulmonary MAC.
Clin Infect Dis. 2007 Aug 1;45:347-51.
Lindeboom JA.
Conservative Wait-and-See Therapy Versus Antibiotic
Treatment for Nontuberculous Mycobacterial Cervicofacial Lymphadenitis in
Children. Clin Infect Dis. 2011;52(2):180-184
Authors
Michelle S. Cespedes, M.D.,
Judith A. Aberg, M.D.
www.antimicrobe.org